Table 1.
Model parameters of adult smokers participating in eTOEP (February 2004–May 2007)
| Parameters | Base case | Source | ||
|---|---|---|---|---|
| Quit rates (strategies) | Men % (95% CI) |
Women % (95% CI) |
All % (95% CI) |
Clinical trial |
| Physicians and pharmacists (both) | 17% (9% to 26%) | 9% (5% to 13%) | 11% (7% to 15%) | |
| Physicians only | 7% (0% to 14%) | 3% (0% to 6%) | 5% (1% to 8%) | |
| Pharmacists only | 9% (2% to 15%) | 8% (3% to 12%) | 8% (4% to 12%) | |
| No training (none) | 10% (3% to 17%) | 8% (4% to 12%) | 9% (5% to 12%) | |
| Prevalence of smoking intensity | Men | Women | Rogers et al., 2005 | |
| Heavy smokers (≥2 packs a day) | 13% | 6% | ||
| Light smokers (1–2 packs a day) | 56% | 47% | ||
| Very light smokers (<1 pack a day) | 31% | 47% | ||
| Prevalence of former smoking intensity | Men | Women | Rogers et al., 2005 | |
| Former heavy smokers (≥2 packs a day) | 25% | 12% | ||
| Former light smokers (1–2 packs a day) | 57% | 40% | ||
| Former very light smokers (<1 pack a day) | 18% | 48% | ||
| Life expectancy (for smokers and former smokers) | - | Rogers et al., 2005 | ||
| Health-related quality-of-life weights | - | Fiscella and Franks, 1996 | ||
| Discount rate | 3% | Gold et al., 1996 | ||
Abbreviations: eTOEP, The Health Care Team Approach to Smoking Cessation: Enhanced Tobacco Outreach Education Program; CI, confidence interval.
Sources:
Fiscella K, Franks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. JAMA 1996;275(16):1247–1251.
Lipscomb J, Weinstein MC, Torrance GW. Time Preference. In: Gold MR, Siegel JE, Russel LB, et al., eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press 2005:214–235.
Rogers RG, Hummer RA, Krueger PM, et al. Mortality attributable to cigarette smoking in the United States. Population and Development Review 2005;31(2):259 – 292